Auditory Stimulation for Insomnia and Depression
Megadott ok: unable to obtain equipment needed for study
A legfontosabb adatok
- Hol
- Winston-Salem (Egyesült Államok)A helyszín megnézése
Helyszínek itt: Egyesült Államok
- Wake Forest University Health SciencesWinston-Salem, Egyesült ÁllamokNo longer taking part
A vizsgálat adatai
- Ki végzi
- Wake Forest University Health Sciences
- Azonosító
- NCT07553364
- A regiszteradat frissítve
- 2026. augusztus 27.
- Eredeti leírás
The goal of this clinical trial is to determine if alpha phase-locked auditory stimulation can improve sleep in people with insomnia and depression. The main goals of the pilot study are the following:A teljes eredeti leírásKevesebb
Feasibility of Using Alpha Phase-Locked Auditory Stimulation for Insomnia Symptoms in People With Depression
The goal of this clinical trial is to determine if alpha phase-locked auditory stimulation can improve sleep in people with insomnia and depression. The main goals of the pilot study are the following:
Determine whether alpha phase-locked auditory stimulation (active stimulation) improves objective and subjective sleep in individuals with insomnia and depression.
The study team hypothesizes that active auditory stimulation will reduce objective and subjective sleep onset latency (SL) and wake after sleep onset (WASO) compared to a sham stimulation.
Participants will:
* Wear Elemind Neuromod headband nightly for 4 weeks (1 week baseline, 1 week active/sham stimulation, 1 week washout, and 1 week opposite condition - active/sham stimulation) * Wear actigraphy watch for duration of the study * Complete questionnaires regarding their sleep, mood, and satisfaction with the device
Bevonási feltételek: Ability to complete overnight EEG study including placement of EEG leads; Ability to read and understand English; Presence of Insomnia; Moderate Depression; Home internet and smartphone (Android or Apple) device access.
Kizáró feltételek: Has active implanted device ( e.g. intracranial device, cochlear implant); Currently taking medications that could alter EEG; Presence of restless leg syndrome; Significant neurological disease (e.g. Parkinson's disease, epilepsy); Diagnosed with schizophrenia, bipolar disorder, substance use disorder, or presence of current suicidal ideation; Presence of severe, untreated sleep apnea; Currently deaf or experiencing hearing loss or using hearing aids; Currently pregnant.